Bubblr (BBLR) 10-Q 22 Aug 22 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2022	Aug. 22, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2022
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	333-260902
Entity Registrant Name	Bubblr, Inc.
Entity Central Index Key	0001873722
Entity Tax Identification Number	86-2355916
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	21 West 46th Street
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	647
Local Phone Number	646 2263
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		157,220,463

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 55,932	$ 62,967
Accounts receivable	10,776	17,966
Advances receivable	73,020	80,251
Total current assets	139,728	161,184
Non-current Assets:
Property and equipment, net	54,835	69,620
Intangible assets, net	1,300,341	1,627,010
Total non-current assets	1,355,176	1,696,630
TOTAL ASSETS	1,494,904	1,857,814
Current Liabilities:
Accounts payable	135,461	200,666
Dividends payable	16,754
Accrued interest	45,610	21,415
Loan payable, current portion	12,061	13,400
Loan payable - related party	403,644	509,339
Total current liabilities	613,530	744,820
Non-current liabilities:
Convertible note payable - net of discount of $34,856 and $69,714	2,252,924	2,218,066
Loan payable,  non-current portion	15,398	22,518
Warrant derivative liability	441,945
Total non-current liabilities	2,710,267	2,240,584
Total Liabilities	3,323,797	2,985,404
Stockholders' Deficit
Common stock, $0.01 par value, 3,000,000,000 shares authorized; 157,191,418 and 140,186,096 shares issued and outstanding at June 30, 2022 and December 31, 2021	1,571,915	1,401,861
Additional paid-in capital	10,121,449	5,478,801
Deferred stock compensation	(2,165,450)
Accumulated deficit	(11,794,731)	(8,385,496)
Accumulated other comprehensive income	437,923	377,244
Total Stockholders' Deficit	(1,828,893)	(1,127,590)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	1,494,904	1,857,814
Series A Preferred Stock [Member]
Stockholders' Deficit
Preferred Stock, $0.001 par value, 25,000,000 shares authorized
Series C Preferred Stock [Member]
Stockholders' Deficit
Preferred Stock, $0.001 par value, 25,000,000 shares authorized	$ 1

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Debt Instrument, Unamortized Discount (Premium), Net	$ 34,856	$ 69,714
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	25,000,000	25,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	3,000,000,000	3,000,000,000
Common Stock, Shares, Issued	157,191,418	140,186,096
Common Stock, Shares, Outstanding	157,191,418	140,186,096
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1	1
Preferred Stock, Shares Issued	1	1
Preferred Stock, Shares Outstanding	1	1
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	2,000	2,000
Preferred Stock, Shares Issued	903	0
Preferred Stock, Shares Outstanding	903	0

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating Expenses
General and administrative	$ 16,309	$ 17,579	$ 27,428	$ 90,682
Professional fees	2,095,727	877,149	2,288,556	1,672,295
Market and regulation costs	44,595	19,691	82,188	33,022
Compensation	172,547	176,360	313,491	345,323
Amortization and depreciation	100,859	95,851	208,454	190,695
Research and development	52,694	135,799	113,955	263,388
Total operating expense	2,482,731	1,322,429	3,034,072	2,595,405
Operating loss	(2,482,731)	(1,322,429)	(3,034,072)	(2,595,405)
Other income (expense)
Interest income	402	460	854	626
Gain on debt settlement		5,000		5,000
Interest expense	(30,420)	(3,004)	(445,264)	(7,804)
Gain on change in fair value of warrant derivative liability	275,178		251,287
Foreign currency transaction loss	(121,307)	(7,149)	(162,014)	(13,814)
Total other income (expense)	123,853	(4,693)	(355,137)	(15,992)
Net loss before income tax	(2,358,878)	(1,327,122)	(3,389,209)	(2,611,397)
Provision for income tax
Net loss after income tax	(2,358,878)	(1,327,122)	(3,389,209)	(2,611,397)
Other comprehensive income (loss)
Foreign currency translation gain	47,306	6,394	60,679	27,353
Total other comprehensive income (loss)	47,306	6,394	60,679	27,353
Net comprehensive loss	$ (2,311,572)	$ (1,320,728)	$ (3,328,530)	$ (2,584,044)
Net loss per common share, basic and diluted	$ (0.02)	$ (0.01)	$ (0.02)	$ (0.02)
Weighted average number of common shares outstanding, basic and diluted	141,753,945	140,102,076	141,124,825	140,102,076

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Preferred Stock [Member] Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Deferred Compensation, Share-Based Payments [Member]	Retained Earnings [Member]	Comprehensive Income [Member]	Treasury Stock [Member]	Total
Balance -March 31, 2022 at Dec. 31, 2020				$ 1,325,652	$ 3,704,045		$ (4,692,009)	$ 354,093	$ (60,000)	$ 631,781
Shares, Issued at Dec. 31, 2020	1	2		132,565,225
Conversion of Preferred B shares to common shares		$ 0		$ 27	5,973					6,000
[custom:PreferredBSharesConvertedToCommonSharesShares]		(2)		2,650
Issuance of Special 2019 Series A Preferred Stock from Treasury to related party in satisfaction of debt									60,000	60,000
Stock Issued During Period, Shares, Treasury Stock Reissued
Issuance of common shares for Services Advisory Board				$ 3,061	701,015					704,076
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture				306,120
Issuance of common shares for Services - Consulting				$ 240	59,760					60,000
Stock Issued During Period, Shares, Issued for Services				24,000
Net loss							(1,284,275)			(1,284,275)
Other comprehensive income								20,959		20,959
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Balance -June 30, 2022 at Mar. 31, 2021			$ 0	$ 1,328,980	4,470,793		(5,976,284)	375,052		198,541
Shares, Issued at Mar. 31, 2021	1			132,897,995
Balance -March 31, 2022 at Dec. 31, 2020				$ 1,325,652	3,704,045		(4,692,009)	354,093	(60,000)	631,781
Shares, Issued at Dec. 31, 2020	1	2		132,565,225
Conversion of Preferred B shares to common shares										6,000
[custom:PreferredBSharesConvertedToCommonSharesShares]				2,650
Net loss										(2,611,397)
Other comprehensive income										27,353
Vesting of common shares issued as deferred compensation
Balance -June 30, 2022 at Jun. 30, 2021				$ 1,401,021	5,297,317		(7,303,406)	381,446		(223,622)
Shares, Issued at Jun. 30, 2021	1			140,102,075
Balance -March 31, 2022 at Mar. 31, 2021			$ 0	$ 1,328,980	4,470,793		(5,976,284)	375,052		198,541
Shares, Issued at Mar. 31, 2021	1			132,897,995
Net loss							(1,327,122)			(1,327,122)
Other comprehensive income								6,394		6,394
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Issuance of common shares for Services - Advisory Board				$ 2,041	826,524					828,565
[custom:StockIssuedDuringPeriodSharesIssuedForServicesAdvisoryBoard]				204,080
Issuance of common shares for debt conversion				$ 70,000						70,000
[custom:CommonStockIssuedForSettlementOfDebtShares]				7,000,000
Balance -June 30, 2022 at Jun. 30, 2021				$ 1,401,021	5,297,317		(7,303,406)	381,446		(223,622)
Shares, Issued at Jun. 30, 2021	1			140,102,075
Balance -March 31, 2022 at Dec. 31, 2021				$ 1,401,861	5,478,801		(8,385,496)	377,244		(1,127,590)
Shares, Issued at Dec. 31, 2021	1			140,186,096
Issuance of common shares for Services Advisory Board				$ 1,480	73,980					75,460
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture				147,960
Issuance of common shares for Services - Consulting				$ 193	8,787					8,980
Stock Issued During Period, Shares, Issued for Services				19,250
Net loss							(1,030,331)			(1,030,331)
Other comprehensive income								13,373		13,373
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Issuance of common shares for Equity Finance Agreement Incentive				$ 7,930	371,884					379,814
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]				793,039
Issue of Series C Preferred shares			$ 1		(1)
Stock Issued During Period, Shares, New Issues			503
Dividend Series C Preferred Shares							(3,272)			(3,272)
Preferred Stock Dividends, Shares
Balance -June 30, 2022 at Mar. 31, 2022			$ 1	$ 1,411,464	5,933,451		(9,419,099)	390,617		(1,683,566)
Shares, Issued at Mar. 31, 2022	1		503	141,146,345
Balance -March 31, 2022 at Dec. 31, 2021				$ 1,401,861	5,478,801		(8,385,496)	377,244		(1,127,590)
Shares, Issued at Dec. 31, 2021	1			140,186,096
Conversion of Preferred B shares to common shares
Net loss										(3,389,209)
Other comprehensive income										60,679
Issuance of common shares as deferred compensation						(2,259,600)
[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]				8,400,000
Vesting of common shares issued as deferred compensation										94,150
Balance -June 30, 2022 at Jun. 30, 2022			$ 1	$ 1,571,915	10,121,449	(2,165,450)	(11,794,731)	437,923		(1,828,893)
Shares, Issued at Jun. 30, 2022	1		903	157,191,418
Balance -March 31, 2022 at Mar. 31, 2022			$ 1	$ 1,411,464	5,933,451		(9,419,099)	390,617		(1,683,566)
Shares, Issued at Mar. 31, 2022	1		503	141,146,345
Issuance of common shares for Services - Consulting				$ 76,451	1,916,630					1,993,081
Stock Issued During Period, Shares, Issued for Services				7,645,073
Net loss							(2,358,878)			(2,358,878)
Other comprehensive income								47,306		47,306
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Issue of Series C Preferred shares			$ 0		95,768					95,768
Stock Issued During Period, Shares, New Issues			400
Dividend Series C Preferred Shares							(16,754)			(16,754)
Preferred Stock Dividends, Shares
Issuance of common shares as deferred compensation				$ 84,000	2,175,600	(2,259,600)
[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]				8,400,000
Vesting of common shares issued as deferred compensation						94,150				94,150
[custom:VestingOfDeferredStockBasedCompensationShares]
Balance -June 30, 2022 at Jun. 30, 2022			$ 1	$ 1,571,915	$ 10,121,449	$ (2,165,450)	$ (11,794,731)	$ 437,923		$ (1,828,893)
Shares, Issued at Jun. 30, 2022	1		903	157,191,418

Consolidated Statements of Cash

Consolidated Statements of Cashflows - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss				$ (3,389,209)	$ (2,611,397)
Net loss to net cash used in operating activities:
Stock based compensation				2,077,521	1,592,641
Vesting of deferred stock based compensation	$ 94,150			94,150
Stock based finance incentive				379,814
Gain on settlement of debt		$ (5,000)			(5,000)
Gain on change in fair value of warrant derivative liability	(275,178)			(251,287)
Amortization of debt discount				39,856
Amortization of intangible asset				187,621	185,088
Depreciation				7,826	5,746
Changes in operating assets and liabilities:
Increase (decrease) in accounts receivable				4,945	(3,957)
Increase (decrease) in accrued interest				24,283	(12,262)
Increase (decrease) in accounts payables				(57,572)	(10,662)
Net cash used in operating activities				(882,052)	(859,803)
Cash flows from investing activities
Purchase of fixed assets				0	(1,330)
Purchase of intangible assets				(19,228)	(51,830)
Net cash used in investing activities				(19,228)	(53,160)
Cash flows from financing activities
Payment of dividends	(3,272)			(3,272)
Proceeds from loans payable				15,000
Repayment of loans payable				(26,434)	(5,338)
Repayment of loans payable - related party				(77,940)	(303,068)
Proceeds from loans payable - related party				19,709
Net proceeds from issuance of Series C Preferred Stock				789,000
Proceeds from issuance of convertible notes payable					2,007,578
Net cash provided by financing activities				716,063	1,699,172
Effects of exchange rate changes on cash				178,182	2,227
Net Change in Cash				(7,035)	788,436
Cash - Beginning of Period/Year			$ 96,602	62,967	96,602	$ 96,602
Cash - End of Period/Year	$ 55,932	$ 885,038		55,932	885,038	$ 62,967
Supplemental information:
Cash paid for interest				6,332	7,804
Cash paid for taxes
Non-cash investing and financing activities
Original issue discount on convertible notes					104,572
Common stock issued for conversion of debt					70,000
Special 2019 Series A Preferred Stock issued from Treasury to related party in satisfaction of debt					60,000
Common stock issued to related party for conversion of Series B Preferred Stock			$ 6,000		6,000
Warrant liability				721,275
Declared dividends				$ 16,754

NOTE 1 - ORGANIZATION, BUSINESS

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY	NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY Organization and Operations On March 26, 2020 Bubblr Holdings Ltd. (a UK company formed on February 18, 2016) merged into U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation formed on October 22, 2019, and became a 100% (“the Company”). Bubblr, Inc. is a Mobile Application software company that is currently developing its disruptive Internet Search Mechanism and seeking license opportunities for a next-generation solution designed to create an alternative economic model. Going Concern Matters The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $3,328,530 $11,794,731 $473,802 Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. See Note 13 – Subsequent Events. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists a substantial doubt about the ability of the Company to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. COVID-19 A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company instituted some temporary precautionary measures intended to help ensure the well-being of its employees and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position as of at June 30, 2022. Most of the restrictions imposed by governments worldwide have now been relaxed. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities at the date of issuance of these financial statements. These estimates may change, as new events occur, and additional information is obtained.

NOTE 2 - SIGNIFICANT ACCOUNTING

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company uses the Black Scholes Options Pricing Model to estimate the value of its derivative liabilities, and remeasures them at each reporting period. Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the six months ended June 30, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments that are adjusted to fair market value on reporting dates. At June 30, 2022, the warrant liabilities balance was $441,945 Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation–Stock Compensation, ). Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement, or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three and six months ended June 30, 2022 and 2021, the following outstanding stock was excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. June 30, 2022 2021 (Shares) (Shares) Series C Preferred Stock 3,384,135 — Warrants 2,358,101 — Convertible Notes 2,027,127 1,836,652 Total 7,769,363 1,836,652 Beneficial Conversion Feature In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with “Conversion and Other Options” and ASC subtopic 815-40 “Hedging—Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company early-adopted the new guidance on January 1, 2021 . As the result of the adoption of this ASU, no beneficial conversion feature was recorded on convertible notes described in Note 7 – Convertible Notes Payable. Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. June 30, December 31. 2022 2021 Period-end GBP£:US$ exchange rate 1.2174 1.3527 Annual average GBP£:US$ exchange rate 1.299 1.3767 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Losses on foreign exchange transactions totaling $162,014 $13,814 Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. As of June 30, 2022 and December 31, 2021, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies which are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”) which is charged at 25% of any “taxable diverted profits”. The DPT has had effect since April 1, 2015 and may apply in circumstances including: (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and as a result a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

NOTE 3 _ ACCOUNTS RECEIVABLE

NOTE 3 – ACCOUNTS RECEIVABLE	6 Months Ended
	Jun. 30, 2022
Credit Loss [Abstract]
NOTE 3 – ACCOUNTS RECEIVABLE	NOTE 3 – ACCOUNTS RECEIVABLE As of June 30, 2022 and December 31, 2021, accounts receivable consisted of the following: June 30, December 31, 2022 2021 Deposit $ 2,434 $ 2,682 UK VAT Receivable 8,342 15,084 Prepayments — 200 Accounts receivable $ 10,776 $ 17,966 Any nominal change in the deposit value is due to exchange rate fluctuation .

NOTE 4 _ ADVANCES RECEIVABLE

NOTE 4 – ADVANCES RECEIVABLE	6 Months Ended
	Jun. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
NOTE 4 – ADVANCES RECEIVABLE	NOTE 4 – ADVANCES RECEIVABLE As of June 30, 2022 and December 31, 2021, cash advances consisted of the following: June 30, December 31, 2022 2021 Advance principal receivable -G $ 48,163 $ 54,529 Advance principal receivable -J 19,480 21,643 Interest due 5,377 4,079 Total advances receivable $ 73,020 $ 80,251 The advance labelled Advance principal receivable-G carries an interest rate of 3% The advance principal labelled Advance receivable -J is non-interest bearing. The Company has the expectation that both outstanding advances will be repaid to the Company within the next 12 months. Any difference on the Advance principal is due to currency translation.

NOTE 5 - PROPERTY AND EQUIPMENT

NOTE 5 - PROPERTY AND EQUIPMENT	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
NOTE 5 - PROPERTY AND EQUIPMENT	NOTE 5 - PROPERTY AND EQUIPMENT As of June 30, 2022 and December 31, 2021, property and equipment consisted of the following: Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2021 $ 63,576 $ 31,500 $ 629 $ 95,705 Additions — — — — Effects of currency translation ( 6,353 ) ( 3,149 ) ( 63 ) ( 9,565 ) At June 30, 2022 $ 57,223 $ 28,351 $ 566 $ 86,140 Less accumulated depreciation At December 31, 2021 $ 14,092 $ 11,710 $ 283 $ 26,085 Depreciation expense 3,044 4,725 57 7,826 Effects of currency translation ( 1,407 ) ( 1,170 ) ( 29 ) ( 2,606 ) At June 30, 2022 $ 15,729 $ 15,265 $ 311 $ 31,305 Net book value At June 30, 2022 $ 41,494 $ 13,086 $ 255 $ 54,835 At December 31, 2021 $ 49,484 $ 19,790 $ 346 $ 69,620 During the six months ended June 30, 2022 and 2021, the Company recorded purchases of $0 $1,330 $7,826 $5,746

NOTE 6 - INTANGIBLE ASSETS

NOTE 6 - INTANGIBLE ASSETS	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
NOTE 6 - INTANGIBLE ASSETS	NOTE 6 - INTANGIBLE ASSETS Patents A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa and New Zealand. A Notice of Approval has also been issued for Canada. The patent is currently pending in the following areas: Australia, European Union and the United Kingdom. Patents are reported at cost, less accumulated amortization and accumulated impairment loss. Costs includes expenditure that is directly attributable to the acquisition of the asset. Once a patent is providing economic benefit to the Company, amortization is provided on a straight-line basis on all patents over their expected useful lives of 20 years Intellectual Property Intellectual Property capitalizes costs of the Company’s qualifying internal research and developments . 7 years Trademarks The Company has the following trademarks Mark Category Proprietor Country Class(es) Status Reg. Date. File No. CITIZENS JOURNALIST Words Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206382.EM.01 CITIZENS JOURNALIST Word Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206382.GB.01 CITIZENS JOURNALIST Words Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206382.GB.02 CITIZENS JOURNALIST Word Bubblr Limited United States 9 38 41 42 REGD-DEC USE 08-Feb-2022 206382.US.01 CITIZENS JOURNALIST Words and Colour Device Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206383.EM.01 CITIZENS JOURNALIST Series of Logos Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206383.GB.01 CITIZENS JOURNALIST Words and Colour Device Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206383.GB.02 CITIZENS JOURNALIST Words and Device Bubblr Limited United States 9 38 41 42 ACCEPTED 206383.US.01 BAU NOT OK/BAU Not OK Series of Marks Bubblr Limited United Kingdom 9 38 REGISTERED 11-Oct-2019 208674.GB.01 NEWZMINE/NewzMine Series of Marks Bubblr Limited United Kingdom 9 38 42 REGISTERED 25-Dec-2020 227753.GB.01 The Company capitalizes trademark costs where the likelihood of acceptance is expected. Each trademark has been determined to have an infinite useful life and is assessed each reporting period for impairment. If there has been a reduction in the value of the trademark or if the trademark is not successfully registered, the asset will be impaired and charged to expense in the period of impairment. As of June 30, 2022 and December 31, 2021, trademarks consisted of the following: June 30, December 31, 2022 2021 Trademarks: NewzMine TM $ 9,636 $ 9,636 Citizens Journalist™ 25,380 23,193 Effects of currency translation ( 3,282 ) — $ 31,734 $ 32,829 As of June 30, 2022 and December 31, 2021, intangible assets consisted of the following: Cost Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total At December 31, 2021 $ 151,860 $ 32,829 $ 2,861,906 $ 45,745 $ 3,092,340 Additions 17,041 2,187 — — 19,228 Effects of currency translation ( 15,179 ) ( 3,282 ) ( 286,042 ) — ( 304,503 ) At June 30, 2022 $ 153,722 $ 31,734 $ 2,575,864 $ 45,745 $ 2,807,065 Less accumulated amortization At December 31, 2021 $ — $ — $ 1,463,042 $ 2,288 $ 1,465,330 Amortization expense 2,489 — 183,988 1,144 187,621 Effects of currency translation — — ( 146,227 ) — ( 146,227 ) At June 30, 2022 $ 2,489 $ — $ 1,500,803 $ 3,432 $ 1,506,724 Net book value At June 30, 2022 $ 151,233 $ 31,734 $ 1,075,061 $ 42,313 $ 1,300,341 At December 31, 2021 $ 151,860 $ 32,829 $ 1,398,864 $ 43,457 $ 1,627,010 During the six months ended June 30, 2022 and 2021, the Company purchased $19,228 $51,830 $187,621 $185,088 $0 $0 Six months ended June 30 , Patents Intellectual Property Capitalized Acquisition Costs Total 6 months remaining 2022 $ 3,781 $ 76,790 $ 1,144 $ 81,715 2023 7,562 153,580 2,288 163,430 2024 7,562 153,580 2,288 163,430 2025 7,562 153,580 2,288 163,430 2026 7,562 153,580 2,288 163,430 Thereafter 117,204 383,951 32,017 533,172 $ 151,233 $ 1,075,061 $ 42,313 $ 1,268,607

NOTE 7 - CONVERTIBLE NOTES PAYA

NOTE 7 - CONVERTIBLE NOTES PAYABLE	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
NOTE 7 - CONVERTIBLE NOTES PAYABLE	NOTE 7 - CONVERTIBLE NOTES PAYABLE In January 2021 the Company commenced an offering for a convertible promissory note. The offering closed June 30, 2021. Funds raised during the six months ended June 30, 2021 was $2,112,150 $104,572 $2,007,578 18 Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non-assessable shares of common stock of the Company at the conversion price of $1.15 per share. Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share. Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes Interest accrual and debt discount amortization commenced July 1, 2021 upon the closing of the convertible promissory note offering. In November 2021 the Company commenced an offering for a convertible promissory note. The offering closed November 30, 2021. Funds raised as of November 30, 2021 totaled $175,630 18 Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share. Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share. Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes. Interest accrual commenced December 1, 2021 upon the closing of the convertible promissory note offering. At June 30, 2022 and December 31, 2021, convertible notes consisted of the following June 30, December 31, 2022 2021 Promissory notes - issued in fiscal year 2021 $ 2,287,780 $ 2,278,780 Total convertible notes payable 2,287,780 2,278,780 Less: unamortized debt discount (34,856 ) (69,714 ) Less: current portion of convertible notes — — Long-term convertible notes $ 2,252,924 $ 2,218,066 During the six months ended June 30, 2022 and 2021, the Company recorded $22,874 $0 $34,856 $0 $0 6,255

NOTE 8 _ LOAN PAYABLE

NOTE 8 – LOAN PAYABLE	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
NOTE 8 – LOAN PAYABLE	NOTE 8 – LOAN PAYABLE On February 4, 2022 the Company issued a promissory note for the principal sum of $20,000 25% $20,000 $15,000 $5,000 The Company has purchased a vehicle under a capital finance arrangement. The term of this loan is 5 years 6.90% $12,061 $13,400 $15,398 $22,518 $6,434 $5,338 $1,332 $1,549 At June 30, 2022, future minimum payments under the loan, are as follows: Total 2022 (six months remaining in 2022) $ 6,434 2023 12,867 2024 11,816 Thereafter — 31,117 Less: Imputed interest ( 3,658 ) Loan payable 27,459 Loan payable – current 12,061 Loan payable - non-current $ 15,398

NOTE 9 - RELATED PARTY TRANSACT

NOTE 9 - RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
NOTE 9 - RELATED PARTY TRANSACTIONS	NOTE 9 - RELATED PARTY TRANSACTIONS Loans from Related Parties The Company has a loan from our founder, Stephen Morris, with a balance of $385,381 $428,177 On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment. In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD the Company shall pay to Mr. Morris an amount equal to The Company received $0 and $0 proceeds and made repayments of $0 $66,000 Six Months Ended Year Ended December 31, 2022 2021 Beginning balance $ 428,177 $ 500,915 Effects of currency translation (42,796 ) (6,738 ) Loan Payable 385,381 494,177 Less: conversions into preferred stock — (66,000 ) Ending balance $ 385,381 $ 428,177 At December 31, 2020, the Company had loans from two minority shareholders totalling $297,006 $81,162 $19,709 $0 $77,940 $303,068 Six Months Ended Year Ended 2022 2021 Beginning balance $ 81,162 $ 297,006 Effects of currency translation (4,668 ) 6,062 Loan Payable 76,494 303,068 Add: additions 19,709 81,162 Less: repayments (77,940 ) (303,068 ) Ending balance $ 18,263 $ 81,162

NOTE 10 - WARRANT LIABILITY

NOTE 10 - WARRANT LIABILITY	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
NOTE 10 - WARRANT LIABILITY	NOTE 10 - WARRANT LIABILITY The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 11) for derivative accounting consideration under ASC 815, Derivatives and Hedging, and determined that the instrument should be classified as a liability due to reset provisions and variability in exercise price resulting in there being no fixed value or explicit limit to the number of shares to be delivered upon exercise. ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our warrant liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities and used the Black Scholes pricing model to calculate the fair value as of June 30, 2022. The Black Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each warrant is estimated using the Black Scholes valuation model. For the period ended June 30, 2022, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows : Six Months Ended June 30, 2022 Expected term 2.34 2.50 Expected average volatility 212 220% Expected dividend yield 8.33% Risk-free interest rate 1.50 3.04% The following table summarizes the changes in the warrant liabilities during the period ended June 30, 2022: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability as of December 31, 2021 $ — Addition of new warrant liabilities 421,000 Day-one loss 28,043 Change in fair value of warrant liability ( 4,152 ) Warrant liability as of March 31, 2022 $ 444,891 Addition of new warrant liabilities 368,000 Day-one gain ( 95,768 ) Change in fain value of warrant Liability ( 275,178 ) Warrant liability as of June 30, 2022 $ 441,945

NOTE 11 - STOCKHOLDERS_ EQUITY

NOTE 11 - STOCKHOLDERS’ EQUITY	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
NOTE 11 - STOCKHOLDERS’ EQUITY	NOTE 11 - STOCKHOLDERS’ EQUITY Preferred Stock The Company has authorized 25,000,000 $0.001 Special 2019 Series A Preferred Stock The Company has designated one ( 1 $0.001 On March 12, 2021, the Company amended the designation of the Special 2019 Series A Preferred shares and removed the right of the holder to convert the Special 2019 Series A Preferred share to 500,000,000 shares of common stock of the Company. The holder of the Special 2019 Series A Preferred Stock is entitled to 60% of all votes entitled to vote at each meeting of stockholders of the Corporation (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Corporation for their action or consideration. As of June 30, 2022 and December 31, 2021, the Company had 1 Series B Preferred Stock At June 30, 2022 and December 31, 2021, the Company had designated 0 0 $0.001 Prior to the retirement of the Series B Preferred Stock, the following designations were in effect: Holders of the Series B Preferred Stock shall after two years of issuance, convert this Class B Preferred Stock based on each Class B Preferred Share equaling .00001% of the total issued and outstanding Common shares of the Company. In the event of a merger, reorganization, recapitalization or similar event of or with respect to the Corporation (other than a Corporate Change in which the Corporation is the surviving entity), this Class B Preferred Stock shall be converted based on each Class B Preferred Share equaling .00001% of the total issued and outstanding shares of common stock of the Company During 2021, the Company converted the 2 2,650 $6,000 As of June 30, 2022 and December 31, 2021, the Company had 0 0 Series C Convertible Preferred Stock On March 4, 2022, the Company filed a Certificate of Designation with the Wyoming Secretary of State, which established 2,000 $1,200 As of June 30, 2022 the Company recorded the following transaction in respect of the dividend due on its Series C Convertible Preferred Stock Dividend liability as of December 31, 2021 $ — Dividend declared 3,272 Dividend liability as of March 31, 2022 $ 3,272 Dividend paid (3,272 ) Dividend declared 16,754 Dividend liability as of June 30, 2022 $ 16,754 The Company has the right to redeem the Series C Convertible Preferred Stock, in accordance with the following schedule: · If all of the Series C Convertible Preferred Stock are redeemed within 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days’ of written notice at a price equal to 115% of the Stated Value together with any accrued but unpaid dividends · If all of the Series C Convertible Preferred Stock are redeemed after 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and · The Company shall pay a dividend of 8% The Series C Convertible Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations (as set forth in the Certificate of Designation). Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $1,200 of such share by the Conversion Price of $0.3202 . As per section 5(b) the fixed conversion price will be 80% of the lowest traded price for the Company’s common stock during the fifteen(15) Trading Days immediately preceding, but not including the conversion date On March 4, 2022, the Company entered into a Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), whereby GHS agreed to purchase, in tranches, up to $700,000 700 On March 4, 2022, the Company issued to GHS the first tranche of 300 35 941,599 75% GHS delivered gross proceeds of $266,000 On March 9, 2022, the Company entered a Securities Purchase Agreement with Proactive Capital Partners LP (“Proactive”), whereby Proactive agreed to purchase 160 The Company agreed to issue Proactive commitment shares of 8 472,205 75% On March 9, the Company issued 168 shares of Series C Convertible Preferred stock to Proactive Capital Partners LP as per the Securities Purchase Agreement. Proactive delivered gross proceeds of $155,000 to the Company (excluded were legal fees). On April 24, 2022 the Company issued the second tranche of 200 562,149 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. GHS delivered gross proceeds of $184,000 On May 25, 2022 the Company issued the third tranche of 100 281,074 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. GHS delivered gross proceeds of $92,000 On June 24, 2022 the Company issued the fourth tranche of 100 281,074 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. GHS delivered gross proceeds of $92,000 As a result of the above transactions, the Company received total net proceeds of $789,000 $721,275 has been allocated to the warrants and Series C Preferred Stock based on the warrants’ fair market values on each contract date, with the residual loss of $28,043 $95,768 903 0 Common Stock The Company has authorized 3,000,000,000 $0.01 During the six months ended June 30, 2022 and 2021, the Company issued common shares as follows: Six months ended June, 2021 · 510,200 $1,532,641 · 24,000 $60,000 · 2,650 $6,000 · 7,000,000 $70,000 Six months ended June 30, 2022 · 8,400,000 $2,259,600 · 147,960 $75,460 · 7,664,323 $2,002,061 · 587,039 $379,814 · 206,000 As at June 30, 2022 and December 31, 2021, the Company had 157,191,418 140,186,096 Warrants The Company identified conversion features embedded within warrants issued during the period ended June 30, 2022. The Company has determined that the conversion feature of the Warrants represents an embedded derivative since the conversion price includes a reset provision which could cause adjustments in redemption value and number of shares issued upon exercise (see Note 10 Warrant Liability). A summary of activity during the period ended June 30, 2022 follows: Warrants Outstanding Weighted Average Number of Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2021 — $ — — Granted 2,538,101 0.32 4.77 Exercised — — — Forfeited/canceled — — — Outstanding, June 30, 2022 2,538,101 $ 0.32 4.77 Exercisable Warrants, June 30, 2022 2,538,101 $ 0.32 4.77 The following table summarizes information relating to outstanding and exercisable warrants as of June 30, 2022: Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life Weighted Average Number of Weighted Average Warrants Exercise Price Shares Exercise Price 941,599 4.68 $ 0.34 941,599 $ 0.34 472,205 4.69 0.34 472,205 0.34 562,149 4.82 0.35 562,149 0.35 281,074 4.90 0.22 281,074 0.22 281,074 4.99 0.22 281,074 0.22 2,538,101 4.77 $ 0.32 2,538,101 $ 0.32 As at June 30, 2022 the intrinsic value of the warrants is $263,982 Equity Incentive Plan On May 25, 2022, our board of directors and majority shareholders approved the adoption of the Bubblr, Inc. 2022 Equity Incentive Plan (the “2022 Equity Incentive Plan”) and, unless earlier terminated, will continue until May 25, 2032. A total of 28,400,000 If the employee is terminated for cause, the employee will forfeit the Restricted Stock Units awarded to date. During the six months ended June 30, 2022, the Company issued pursuant to the 2022 Equity Incentive Plan, a total of 8,400,000 The shares were valued at $2,259,600, based on the market price of the common stock on the respective dates of the agreements, which was $0.269 per share, and amortized over their two-year vesting period on a straight-line basis. During the six months ended June 30, 2022, the Company recorded stock-based compensation of $94,150 $2,165,450 4,200,000 shares of performance-based stock compensation are scheduled to vest on each of June 1, 2023 and June 1, 2024, respectively. The Company has elected to treat the award as a single award of 8,400,000 shares that vests ratably over the vesting period. The following table shows the deferred stock compensation activity during the six months ended June 30, 2022: Deferred stock compensation at December 31, 2021 $ — Awards issued 2,259,600 Vesting of stock compensation ( 94,150 ) Deferred stock compensation at June 30, 2022 $ 2,165,450

NOTE 12 - COMMITMENTS AND CONTI

NOTE 12 - COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
NOTE 12 - COMMITMENTS AND CONTINGENCIES	NOTE 12 - COMMITMENTS AND CONTINGENCIES During the six months ended June 30, 2022 and 2021, the Company paid $4,264 $5,115 During the six months ended June 30, 2022 and 2021, the Company paid $1,200 $0 twelve months $200 The Company has entered into an employment agreement with Steven Saunders, our Chief Commercial Officer and Director. The term is three years commencing July 1, 2021. Mr. Saunders is to receive monthly cash compensation of $15,000 reduced by $3,820 until at least $5,000,000 funding has been received through the S-1 offering The Company has entered into an employment agreement with Rik Willard to act as Chief Executive Officer of the Company and as Director. The term is 1 year commencing August 15, 2021. Mr. Willard is to receive monthly cash compensation of $15,000 reduced by $3,000 until at least $5,000,000 funding has been received through the S-1 offering. Mr. Willard was also granted a signing bonus of 102,040 restricted shares, which were issued in June 2021 On May 31, 2022, our board of directors approved amended and restated employment agreements in favor of our Chief Executive Officer, Rik Willard, and our Chief Commercial Officer, Steven Saunders. The employment agreement with Mr. Willard was amended as follows. In addition to his cash compensation the Company agreed to further compensate Mr. Willard in accordance with our May 25, 2022 Equity Incentive Plan (Note 11) with 5,400,000 restricted stock units, which vest 2,700,000 annually over a period of two years. He is also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He is also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Willard agreed to a two year non-solicit restrictive covenant. The agreement will automatically renew for a further year on May 31, 2023. The employment agreement with Mr. Saunders was amended as follows. In addition to his cash compensation the Company agreed to further compensate Mr. Saunders in accordance with our May 25, 2022 Equity Incentive Plan (Note 11) with 3,000,000 restricted stock units, which vests 1,500,000 annually over a period of two years. He is also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He is also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Saunders agreed to a two year non-solicit restrictive covenant The Company entered into employment agreement with Stephen Morris, our Founder and Chief Technology Officer, the term is three years commencing July 1, 2021. Mr. Morris is to receive monthly cash compensation of $15,000 reduced by $4,790 until at least $5,000,000 has been received through the S-1 offering. On March 25, 2022, the Company entered into a service agreement with PCG Advisory, Inc. The term is six months $7,000 $7,000

NOTE 13 - SUBSEQUENT EVENTS

NOTE 13 - SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
NOTE 13 - SUBSEQUENT EVENTS	NOTE 13 - SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date of issuance of these consolidated financial statements and noted the following significant events requiring disclosure. On July 27, 2022, 29,045 $7,000

NOTE 2 - SIGNIFICANT ACCOUNTI_2

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.
Convertible Financial Instruments	Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company uses the Black Scholes Options Pricing Model to estimate the value of its derivative liabilities, and remeasures them at each reporting period.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the six months ended June 30, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments that are adjusted to fair market value on reporting dates. At June 30, 2022, the warrant liabilities balance was $441,945
Stock Based Compensation	Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation–Stock Compensation, ).
Common Stock Purchase Warrants and Derivative Financial Instruments	Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement, or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.
Basic and Diluted Net Loss per Common Share	Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three and six months ended June 30, 2022 and 2021, the following outstanding stock was excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. June 30, 2022 2021 (Shares) (Shares) Series C Preferred Stock 3,384,135 — Warrants 2,358,101 — Convertible Notes 2,027,127 1,836,652 Total 7,769,363 1,836,652
Beneficial Conversion Feature	Beneficial Conversion Feature In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with “Conversion and Other Options” and ASC subtopic 815-40 “Hedging—Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company early-adopted the new guidance on January 1, 2021 . As the result of the adoption of this ASU, no beneficial conversion feature was recorded on convertible notes described in Note 7 – Convertible Notes Payable.
Foreign Currency Translations	Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. June 30, December 31. 2022 2021 Period-end GBP£:US$ exchange rate 1.2174 1.3527 Annual average GBP£:US$ exchange rate 1.299 1.3767 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Losses on foreign exchange transactions totaling $162,014 $13,814
Income Taxes	Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. As of June 30, 2022 and December 31, 2021, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies which are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”) which is charged at 25% of any “taxable diverted profits”. The DPT has had effect since April 1, 2015 and may apply in circumstances including: (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and as a result a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr.
Recent Accounting Pronouncements	Recent Accounting Pronouncements

NOTE 2 - SIGNIFICANT ACCOUNTI_3

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings per Share	June 30, 2022 2021 (Shares) (Shares) Series C Preferred Stock 3,384,135 — Warrants 2,358,101 — Convertible Notes 2,027,127 1,836,652 Total 7,769,363 1,836,652
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Tranlation Adjustments	June 30, December 31. 2022 2021 Period-end GBP£:US$ exchange rate 1.2174 1.3527 Annual average GBP£:US$ exchange rate 1.299 1.3767

NOTE 3 _ ACCOUNTS RECEIVABLE (T

NOTE 3 – ACCOUNTS RECEIVABLE (Tables)	6 Months Ended
	Jun. 30, 2022
Credit Loss [Abstract]
NOTE 3 - ACCOUNTS RECEIVABLE	June 30, December 31, 2022 2021 Deposit $ 2,434 $ 2,682 UK VAT Receivable 8,342 15,084 Prepayments — 200 Accounts receivable $ 10,776 $ 17,966

NOTE 4 _ ADVANCES RECEIVABLE (T

NOTE 4 – ADVANCES RECEIVABLE (Tables)	6 Months Ended
	Jun. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
NOTE 4 - ADVANCES RECEIVABLE - Schedule of Cash Advances	June 30, December 31, 2022 2021 Advance principal receivable -G $ 48,163 $ 54,529 Advance principal receivable -J 19,480 21,643 Interest due 5,377 4,079 Total advances receivable $ 73,020 $ 80,251

NOTE 5 - PROPERTY AND EQUIPME_2

NOTE 5 - PROPERTY AND EQUIPMENT (Tables)	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
NOTE 5 - PROPERTY AND EQUIPMENT - Schedule of Property Pant and Equipment	Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2021 $ 63,576 $ 31,500 $ 629 $ 95,705 Additions — — — — Effects of currency translation ( 6,353 ) ( 3,149 ) ( 63 ) ( 9,565 ) At June 30, 2022 $ 57,223 $ 28,351 $ 566 $ 86,140 Less accumulated depreciation At December 31, 2021 $ 14,092 $ 11,710 $ 283 $ 26,085 Depreciation expense 3,044 4,725 57 7,826 Effects of currency translation ( 1,407 ) ( 1,170 ) ( 29 ) ( 2,606 ) At June 30, 2022 $ 15,729 $ 15,265 $ 311 $ 31,305 Net book value At June 30, 2022 $ 41,494 $ 13,086 $ 255 $ 54,835 At December 31, 2021 $ 49,484 $ 19,790 $ 346 $ 69,620

NOTE 6 - INTANGIBLE ASSETS (Tab

NOTE 6 - INTANGIBLE ASSETS (Tables)	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
NOTE 6 - INTANGIBLE ASSETS - Trademarks	June 30, December 31, 2022 2021 Trademarks: NewzMine TM $ 9,636 $ 9,636 Citizens Journalist™ 25,380 23,193 Effects of currency translation ( 3,282 ) — $ 31,734 $ 32,829
NOTE 6 - INTANGIBLE ASSETS - Schedule of Intangible Assets	Cost Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total At December 31, 2021 $ 151,860 $ 32,829 $ 2,861,906 $ 45,745 $ 3,092,340 Additions 17,041 2,187 — — 19,228 Effects of currency translation ( 15,179 ) ( 3,282 ) ( 286,042 ) — ( 304,503 ) At June 30, 2022 $ 153,722 $ 31,734 $ 2,575,864 $ 45,745 $ 2,807,065 Less accumulated amortization At December 31, 2021 $ — $ — $ 1,463,042 $ 2,288 $ 1,465,330 Amortization expense 2,489 — 183,988 1,144 187,621 Effects of currency translation — — ( 146,227 ) — ( 146,227 ) At June 30, 2022 $ 2,489 $ — $ 1,500,803 $ 3,432 $ 1,506,724 Net book value At June 30, 2022 $ 151,233 $ 31,734 $ 1,075,061 $ 42,313 $ 1,300,341 At December 31, 2021 $ 151,860 $ 32,829 $ 1,398,864 $ 43,457 $ 1,627,010
NOTE 6 - INTANGIBLE ASSETS - Amortization Expense	Six months ended June 30 , Patents Intellectual Property Capitalized Acquisition Costs Total 6 months remaining 2022 $ 3,781 $ 76,790 $ 1,144 $ 81,715 2023 7,562 153,580 2,288 163,430 2024 7,562 153,580 2,288 163,430 2025 7,562 153,580 2,288 163,430 2026 7,562 153,580 2,288 163,430 Thereafter 117,204 383,951 32,017 533,172 $ 151,233 $ 1,075,061 $ 42,313 $ 1,268,607

NOTE 7 - CONVERTIBLE NOTES PA_2

NOTE 7 - CONVERTIBLE NOTES PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
NOTE 7 - CONVERTIBLE NOTES PAYABLE - Schedule of Convertible Notes Payable	June 30, December 31, 2022 2021 Promissory notes - issued in fiscal year 2021 $ 2,287,780 $ 2,278,780 Total convertible notes payable 2,287,780 2,278,780 Less: unamortized debt discount (34,856 ) (69,714 ) Less: current portion of convertible notes — — Long-term convertible notes $ 2,252,924 $ 2,218,066

NOTE 8 _ LOAN PAYABLE (Tables)

NOTE 8 – LOAN PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
NOTE 8 - LOANS PAYABLE - Future Minimum Payments	Total 2022 (six months remaining in 2022) $ 6,434 2023 12,867 2024 11,816 Thereafter — 31,117 Less: Imputed interest ( 3,658 ) Loan payable 27,459 Loan payable – current 12,061 Loan payable - non-current $ 15,398

NOTE 9 - RELATED PARTY TRANSA_2

NOTE 9 - RELATED PARTY TRANSACTIONS (Tables)	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
NOTE 9 - RELATED PARTY TRANSACTIONS - Founder Loan	Six Months Ended Year Ended December 31, 2022 2021 Beginning balance $ 428,177 $ 500,915 Effects of currency translation (42,796 ) (6,738 ) Loan Payable 385,381 494,177 Less: conversions into preferred stock — (66,000 ) Ending balance $ 385,381 $ 428,177

NOTE 10 - WARRANT LIABILITY (Ta

NOTE 10 - WARRANT LIABILITY (Tables)	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
NOTE 10 - WARRANT LIABILITY - Fair Value of Warrant Liabilities Measured on a Recurring Basis	Six Months Ended June 30, 2022 Expected term 2.34 2.50 Expected average volatility 212 220% Expected dividend yield 8.33% Risk-free interest rate 1.50 3.04%
NOTE 10 - WARRANT LIABILITY - Schedule of Changes in Warrant Liabilities	Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability as of December 31, 2021 $ — Addition of new warrant liabilities 421,000 Day-one loss 28,043 Change in fair value of warrant liability ( 4,152 ) Warrant liability as of March 31, 2022 $ 444,891 Addition of new warrant liabilities 368,000 Day-one gain ( 95,768 ) Change in fain value of warrant Liability ( 275,178 ) Warrant liability as of June 30, 2022 $ 441,945

NOTE 11 - STOCKHOLDERS_ EQUITY

NOTE 11 - STOCKHOLDERS’ EQUITY (Tables)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
NOTE 11 - STOCKHOLDERS' EQUITY - Dividend Due on Series C Preferred	Dividend liability as of December 31, 2021 $ — Dividend declared 3,272 Dividend liability as of March 31, 2022 $ 3,272 Dividend paid (3,272 ) Dividend declared 16,754 Dividend liability as of June 30, 2022 $ 16,754
NOTE 11 - STOCKHOLDERS EQUITY - Summary of Warrant Activity	Warrants Outstanding Weighted Average Number of Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2021 — $ — — Granted 2,538,101 0.32 4.77 Exercised — — — Forfeited/canceled — — — Outstanding, June 30, 2022 2,538,101 $ 0.32 4.77 Exercisable Warrants, June 30, 2022 2,538,101 $ 0.32 4.77
NOTE 11 - STOCKHOLDERS EQUITY - Summary of Outstanding Warrants	Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life Weighted Average Number of Weighted Average Warrants Exercise Price Shares Exercise Price 941,599 4.68 $ 0.34 941,599 $ 0.34 472,205 4.69 0.34 472,205 0.34 562,149 4.82 0.35 562,149 0.35 281,074 4.90 0.22 281,074 0.22 281,074 4.99 0.22 281,074 0.22 2,538,101 4.77 $ 0.32 2,538,101 $ 0.32
NOTE 11 - STOCKHOLDERS EQUITY - Deferred Stock Compensation	Deferred stock compensation at December 31, 2021 $ — Awards issued 2,259,600 Vesting of stock compensation ( 94,150 ) Deferred stock compensation at June 30, 2022 $ 2,165,450

NOTE 1 - ORGANIZATION, BUSINE_2

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Oct. 22, 2019
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 2,311,572	$ 1,320,728	$ 3,328,530	$ 2,584,044
Retained Earnings (Accumulated Deficit)	11,794,731		11,794,731		$ 8,385,496
[custom:LiabilitiesCurrentInExcessOfAssetsCurrent-0]	$ 473,802		$ 473,802
U W R L [Member]
Equity Method Investment, Ownership Percentage						100%

NOTE 2 - SIGNIFICANT ACCOUNTI_4

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings per Share (Details) - shares	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Total	7,769,363	1,836,652
Preferred Stock [Member] | Series C Preferred Stock [Member]
Total	3,384,135
Derivative One [Member]
Total	2,358,101
Convertible Notes [Member]
Total	2,027,127	1,836,652

NOTE 2 - SIGNIFICANT ACCOUNTI_5

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Tranlation Adjustments (Details)	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Period-end GBP£:US$ exchange rate	1.2174	1.3527
Annual average GBP£:US$ exchange rate	1.299	1.3767

NOTE 2 - SIGNIFICANT ACCOUNTI_6

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Accounting Policies [Abstract]
Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned, Not Subject to Master Netting Arrangement	$ 441,945		$ 441,945
Foreign Currency Transaction Loss, before Tax	$ 121,307	$ 7,149	$ 162,014	$ 13,814

NOTE 3 - ACCOUNTS RECEIVABLE (D

NOTE 3 - ACCOUNTS RECEIVABLE (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Credit Loss [Abstract]
Deposit	$ 2,434	$ 2,682
UK VAT Receivable	8,342	15,084
Prepayments		200
Accounts receivable	$ 10,776	$ 17,966

NOTE 4 - ADVANCES RECEIVABLE -

NOTE 4 - ADVANCES RECEIVABLE - Schedule of Cash Advances (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Interest due	$ 5,377	$ 4,079
Total advances receivable	73,020	80,251
Advance G W [Member]
Customer Advances, Current	48,163	54,529
Advance J M [Member]
Customer Advances, Current	$ 19,480	$ 21,643

NOTE 4 _ ADVANCES RECEIVABLE (D

NOTE 4 – ADVANCES RECEIVABLE (Details Narrative)	Jun. 30, 2022
Advance G W [Member]
Short-Term Debt, Percentage Bearing Fixed Interest Rate	3%

NOTE 5 - PROPERTY AND EQUIPME_3

NOTE 5 - PROPERTY AND EQUIPMENT - Schedule of Property Pant and Equipment (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 86,140		$ 95,705
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	178,182	$ 2,227
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	31,305		26,085
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	7,826
Temporary Equity, Foreign Currency Translation Adjustments	2,606
Property, Plant and Equipment, Net	54,835		69,620
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	57,223		63,576
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	6,353
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	15,729		14,092
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	3,044
Temporary Equity, Foreign Currency Translation Adjustments	1,407
Property, Plant and Equipment, Net	41,494
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	28,351		31,500
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	3,149
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	15,265		11,710
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	4,725
Temporary Equity, Foreign Currency Translation Adjustments	1,170
Property, Plant and Equipment, Net	13,086		19,790
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	566		629
Property, Plant and Equipment, Additions
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	63
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	311		283
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	57
Temporary Equity, Foreign Currency Translation Adjustments	29
Property, Plant and Equipment, Net	255		346
Total [Member]
Property, Plant and Equipment [Line Items]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	$ 9,565
Automobiles Quarterly [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Net			$ 49,484

NOTE 5 - PROPERTY AND EQUIPME_4

NOTE 5 - PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Payments to Acquire Productive Assets	$ 0	$ (1,330)
Payments to Acquire Productive Assets	0	1,330
Depreciation	$ 7,826	$ 5,746

NOTE 6 - INTANGIBLE ASSETS - Tr

NOTE 6 - INTANGIBLE ASSETS - Trademarks (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 30, 2020
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-Lived Trademarks	$ 31,734	$ 32,829
Trademarks [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	3,282
Newz Mine [Member]
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-Lived Trademarks	9,636		$ 9,636
Citizens Journalist [Member]
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-Lived Trademarks	$ 25,380	$ 23,193

NOTE 6 - INTANGIBLE ASSETS - S

NOTE 6 - INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Patents, Gross	$ 153,722		$ 151,860
Indefinite-Lived Trademarks	31,734		32,829
Capitalized Costs, Proved Properties	45,745		45,745
Finite-Lived Intangible Assets, Gross	2,807,065		3,092,340
Finite-Lived Intangible Assets, Period Increase (Decrease)	19,228	$ 51,830
Finite-Lived Intangible Assets, Accumulated Amortization	1,506,724		1,465,330
Amortization of Intangible Assets	187,621	$ 185,088
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	146,227
Finite-Lived Intangible Assets, Net	1,300,341		1,627,010
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	304,503
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	2,575,864		2,861,906
Finite-Lived Intangible Assets, Period Increase (Decrease)
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	286,042
Finite-Lived Intangible Assets, Accumulated Amortization	1,500,803		1,463,042
Amortization of Intangible Assets	183,988
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	146,227
Finite-Lived Intangible Assets, Net	1,075,061		1,398,864
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)	17,041
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	15,179
Finite-Lived Intangible Assets, Accumulated Amortization	2,489
Amortization of Intangible Assets	2,489
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	151,233		151,860
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)	2,187
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	3,282
Finite-Lived Intangible Assets, Accumulated Amortization
Amortization of Intangible Assets
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	31,734		32,829
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)
Finite-Lived Intangible Assets, Accumulated Amortization	3,432		2,288
Amortization of Intangible Assets	1,144
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	$ 42,313		$ 43,457

NOTE 6 - INTANGIBLE ASSETS - Am

NOTE 6 - INTANGIBLE ASSETS - Amortization Expense (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year	$ 81,715
Finite-Lived Intangible Asset, Expected Amortization, Year Two	163,430
Finite-Lived Intangible Asset, Expected Amortization, Year Three	163,430
Finite-Lived Intangible Asset, Expected Amortization, Year Four	163,430
Finite-Lived Intangible Asset, Expected Amortization, Year Five	163,430
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	533,172
Finite-Lived Intangible Assets, Net	1,300,341	$ 1,627,010
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	1,268,607
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year	3,781
Finite-Lived Intangible Asset, Expected Amortization, Year Two	7,562
Finite-Lived Intangible Asset, Expected Amortization, Year Three	7,562
Finite-Lived Intangible Asset, Expected Amortization, Year Four	7,562
Finite-Lived Intangible Asset, Expected Amortization, Year Five	7,562
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	117,204
Finite-Lived Intangible Assets, Net	151,233	151,860
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year	76,790
Finite-Lived Intangible Asset, Expected Amortization, Year Two	153,580
Finite-Lived Intangible Asset, Expected Amortization, Year Three	153,580
Finite-Lived Intangible Asset, Expected Amortization, Year Four	153,580
Finite-Lived Intangible Asset, Expected Amortization, Year Five	153,580
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	383,951
Finite-Lived Intangible Assets, Net	1,075,061	1,398,864
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	1,075,061
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year	1,144
Finite-Lived Intangible Asset, Expected Amortization, Year Two	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Three	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Four	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Five	2,288
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	32,017
Finite-Lived Intangible Assets, Net	42,313	$ 43,457
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	$ 42,313

NOTE 6 - INTANGIBLE ASSETS (Det

NOTE 6 - INTANGIBLE ASSETS (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)	$ 19,228	$ 51,830
Amortization of Intangible Assets	187,621	185,088
Impairment of Intangible Assets, Finite-Lived	$ 0	$ 0
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Finite-Lived Intangible Assets, Period Increase (Decrease)	$ 17,041
Amortization of Intangible Assets	$ 2,489
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	7 years
Finite-Lived Intangible Assets, Period Increase (Decrease)
Amortization of Intangible Assets	$ 183,988

NOTE 7 - CONVERTIBLE NOTES PA_3

NOTE 7 - CONVERTIBLE NOTES PAYABLE - Schedule of Convertible Notes Payable (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Total convertible notes payable	$ 2,287,780	$ 2,278,780
Less: unamortized debt discount	(34,856)	(69,714)
Less: current portion of convertible notes
Long-term convertible notes	2,252,924	2,218,066
Promissory Notes Issued In Fiscal Year 2021 [Member]
Short-Term Debt [Line Items]
Convertible Debt	$ 2,287,780	$ 2,278,780

NOTE 7 - CONVERTIBLE NOTES PA_4

NOTE 7 - CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Short-Term Debt [Line Items]
Proceeds from Convertible Debt					$ 2,007,578
Interest Expense		$ 30,420	$ 3,004	445,264	7,804
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				$ 3,658
Offering [Member]
Short-Term Debt [Line Items]
Proceeds from Notes Payable					2,112,150
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net			$ 104,572		104,572
Proceeds from Convertible Debt					2,007,578
Debt Instrument, Term				18 months
Debt Instrument, Interest Rate Terms				Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes
Offering [Member] | Voluntary Conversion [Member]
Short-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature				Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non-assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Offering [Member] | Mandatory Conversion [Member]
Short-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature				Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Nov 2021 Offering [Member]
Short-Term Debt [Line Items]
Proceeds from Notes Payable	$ 175,630
Debt Instrument, Term	18 months
Nov 2021 Offering [Member] | Voluntary Conversion [Member]
Short-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature	Voluntary Conversion. Investor may, at his/her/its sole option, at any time after nine (9) months, convert all or any portion of the accrued interest and unpaid principal balance of this Note into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Debt Instrument, Interest Rate Terms	Interest at the rate equal to 2% per annum, computed on the basis of the actual number of days elapsed and a year of 365 days will be due on all outstanding notes.
Nov 2021 Offering [Member] | Mandatory Conversion [Member]
Short-Term Debt [Line Items]
Debt Instrument, Convertible, Terms of Conversion Feature	Mandatory Conversion. Upon sixty (60) days from the date the Company files a Form 10 registration statement with the Securities and Exchange Commission (the “SEC”), all of the accrued interest and unpaid principal balance of this Note shall automatically convert into fully paid and non- assessable shares of common stock of the Company at the conversion price of $1.15 per share.
Convertible Loans [Member]
Short-Term Debt [Line Items]
Interest Expense				$ 22,874	0
Amortization of Debt Discount (Premium)				34,856	0
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				$ 0	$ 6,255

NOTE 8 - LOANS PAYABLE - Future

NOTE 8 - LOANS PAYABLE - Future Minimum Payments (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal Remainder of Fiscal Year	$ 6,434
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two	12,867
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three	11,816
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four
Loans Payable	27,459
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	3,658
Loans Payable, Current	12,061	$ 13,400
Loans Payable, Noncurrent	15,398	$ 22,518
Future Payments Total [Member]
Short-Term Debt [Line Items]
Loans Payable	$ 31,117

NOTE 8 _ LOAN PAYABLE (Details

NOTE 8 – LOAN PAYABLE (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	6 Months Ended
	Apr. 26, 2022	Apr. 26, 2022	Jun. 30, 2022	Jun. 30, 2021	Feb. 04, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Loans Payable, Current			$ 12,061			$ 13,400
Loans Payable, Noncurrent			15,398			$ 22,518
Payments of Financing Costs			6,434
Payments for Loans			$ 26,434	$ 5,338
White Lion Note [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount					$ 20,000
Debt Instrument, Interest Rate, Effective Percentage					25%
Payments of Debt Issuance Costs	$ 20,000
Proceeds from Notes Payable	$ 15,000
Amortization of Debt Discount (Premium)		$ 5,000
Vehicle [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Effective Percentage			6.90%
Debt Instrument, Term			5 years
Interest Expense, Long-Term Debt			$ 1,332	$ 1,549

NOTE 9 - RELATED PARTY TRANSA_3

NOTE 9 - RELATED PARTY TRANSACTIONS - Founder Loan (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Add: additions	$ 19,709
Less: repayments	26,434	5,338
Founder Loan [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount	428,177		$ 500,915
Effects of currency translation	(42,796)		(6,738)
Less: conversions into preferred stock	0	66,000	(66,000)
Principal Amount Outstanding of Loans Held-in-portfolio	385,381		428,177
Founder Loan [Member] | Founder Loan [Member]
Related Party Transaction [Line Items]
Loan Payable	385,381		494,177
Shareholder Loans [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount	18,263		81,162	$ 297,006
Effects of currency translation	(4,668)		6,062
Loan Payable	76,494		303,068
Add: additions	19,709	0	81,162
Less: repayments	$ (77,940)	$ (303,068)	$ (303,068)

NOTE 9 - RELATED PARTY TRANSA_4

NOTE 9 - RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Short-Term Debt [Line Items]
Proceeds from Related Party Debt	$ 19,709
Payments for Loans	(26,434)	(5,338)
Founder Loan [Member]
Short-Term Debt [Line Items]
Principal Amount Outstanding of Loans Held-in-portfolio	$ 385,381		$ 428,177
Debt Instrument, Call Feature	On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment.
Debt Instrument, Payment Terms	In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD the Company shall pay to Mr. Morris an amount equal to
Conversion of Stock, Amount Converted	$ 0	66,000	(66,000)
Debt Instrument, Face Amount	428,177		500,915
Shareholder Loans [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount	18,263		81,162	$ 297,006
Proceeds from Related Party Debt	19,709	0	81,162
Payments for Loans	$ 77,940	$ 303,068	303,068
Shareholder Loans Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount			$ 81,162

NOTE 10 - WARRANT LIABILITY - F

NOTE 10 - WARRANT LIABILITY - Fair Value of Warrant Liabilities Measured on a Recurring Basis (Details)	6 Months Ended
	Jun. 30, 2022
Derivative [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	21,200%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	220%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	8.33%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	150%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	3.04%
Minimum [Member]
Derivative [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	2 years 4 months 2 days
Maximum [Member]
Derivative [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	2 years 6 months

NOTE 10 - WARRANT LIABILITY - S

NOTE 10 - WARRANT LIABILITY - Schedule of Changes in Warrant Liabilities (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability, Subject to Master Netting Arrangement, before Offset	$ 441,945	$ 444,891	$ 441,945
Increase (Decrease) in Derivative Liabilities	368,000	421,000
Derivative, Loss on Derivative	95,768	28,043	$ 28,043
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	$ 275,178	$ 4,152

NOTE 11 - STOCKHOLDERS' EQUITY

NOTE 11 - STOCKHOLDERS' EQUITY - Dividend Due on Series C Preferred (Details) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Class of Stock [Line Items]
Dividends Payable, Current	$ 16,754	$ 3,272		$ 16,754
Dividends, Preferred Stock	16,754	3,272
Payments of Dividends	(3,272)			(3,272)
Stock Issued During Period, Value, Issued for Services	1,993,081	$ 8,980	$ 60,000
[custom:PreferredBSharesConvertedToCommonSharesValue]			$ (6,000)		(6,000)
[custom:StockIssuedDuringPeriodValueIssuedForDeferredCompensation]
Founder Loan [Member]
Class of Stock [Line Items]
[custom:PreferredBSharesConvertedToCommonSharesValue]					$ 6,000
Advisory Board [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Issued for Services				147,960	510,200
Stock Issued During Period, Value, Issued for Services				$ 75,460	$ 1,532,641
Investor Relations [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Issued for Services				7,664,323	24,000
Stock Issued During Period, Value, Issued for Services				$ 2,002,061	$ 60,000
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Issued for Services	7,645,073	19,250	24,000
Stock Issued During Period, Value, Issued for Services	$ 76,451	$ 193	$ 240
[custom:PreferredBSharesConvertedToCommonSharesShares]			2,650		2,650
[custom:PreferredBSharesConvertedToCommonSharesValue]			$ (27)
[custom:CommonStockIssuedForConversionOfDebt]					7,000,000
[custom:CommonStockIssuedForConversionOfDebtValue]					$ 70,000
[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]	8,400,000			8,400,000
[custom:StockIssuedDuringPeriodValueIssuedForDeferredCompensation]	$ (84,000)
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]		793,039
Deferred Compensation, Share-Based Payments [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Issued for Services
[custom:PreferredBSharesConvertedToCommonSharesValue]
[custom:StockIssuedDuringPeriodValueIssuedForDeferredCompensation]	$ 2,259,600			$ 2,259,600
Commitment Shares To G H S [Member]
Class of Stock [Line Items]
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]				587,039
[custom:StockIssuedDuringPeriodEquityFinanceAgreementValuie]				$ 379,814
Termination Agreement White Lion [Member]
Class of Stock [Line Items]
[custom:StockIssuedDuringPeriodTerminationReleaseAgreementShares]				206,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage				8%
Series C Preferred Stock [Member] | Redeemed Within 90 Days [Member]
Class of Stock [Line Items]
Debt Instrument, Redemption, Description				If all of the Series C Convertible Preferred Stock are redeemed within 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days’ of written notice at a price equal to 115% of the Stated Value together with any accrued but unpaid dividends
Series C Preferred Stock [Member] | Redeemed After 90 Days [Member]
Class of Stock [Line Items]
Debt Instrument, Redemption, Description				If all of the Series C Convertible Preferred Stock are redeemed after 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and

NOTE 11 - STOCKHOLDERS EQUITY -

NOTE 11 - STOCKHOLDERS EQUITY - Summary of Warrant Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	2,538,101
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.32
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 9 months 7 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted	2,538,101
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.32
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageExercisePrice]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share
Warrants Granted [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 9 months 7 days
Warrants Exercised [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Warrants Forfeited [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms

NOTE 11 - STOCKHOLDERS EQUITY_2

NOTE 11 - STOCKHOLDERS EQUITY - Summary of Outstanding Warrants (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Jun. 24, 2022	May 25, 2022	Apr. 24, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	2,538,101
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 9 months 7 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.32
G H S [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	941,599
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 8 months 4 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34
Proactive [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	472,205
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 8 months 8 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34
G H S Tranche 2 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	562,149				562,149
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 9 months 25 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.35
G H S Tranche 3 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	281,074			281,074
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 10 months 24 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.22
G H S Tranche 4 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	281,074		281,074
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 11 months 26 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.22

NOTE 11 - STOCKHOLDERS EQUITY_3

NOTE 11 - STOCKHOLDERS EQUITY - Deferred Stock Compensation (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Deferred Compensation Equity	$ 2,165,450	$ 2,165,450
[custom:StockIssuedDuringPeriodValueIssuedForDeferredCompensation]
[custom:VestingOfDeferredStockBasedCompensation]	94,150	94,150
Deferred Compensation, Share-Based Payments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
[custom:StockIssuedDuringPeriodValueIssuedForDeferredCompensation]	2,259,600	$ 2,259,600
[custom:VestingOfDeferredStockBasedCompensation]	$ 94,150

NOTE 11 - STOCKHOLDERS_ EQUIT_2

NOTE 11 - STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)		1 Months Ended			2 Months Ended	3 Months Ended			6 Months Ended		12 Months Ended
	Mar. 09, 2022	Jun. 24, 2022	May 25, 2022	Apr. 24, 2022	Mar. 12, 2021	Jun. 30, 2022	Mar. 31, 2022	Mar. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2022	Mar. 04, 2022
Class of Stock [Line Items]
Preferred Stock, Shares Authorized						25,000,000			25,000,000		25,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001			$ 0.001		$ 0.001
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number						2,538,101			2,538,101
Derivative, Loss on Derivative						$ 95,768	$ 28,043		$ 28,043
Common Stock, Shares Authorized						3,000,000,000			3,000,000,000		3,000,000,000
Common Stock, Par or Stated Value Per Share						$ 0.01			$ 0.01		$ 0.01
Common Stock, Shares, Issued						157,191,418			157,191,418		140,186,096
Common Stock, Shares, Outstanding						157,191,418			157,191,418		140,186,096
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding						$ 263,982			$ 263,982
[custom:VestingOfDeferredStockBasedCompensation]						94,150			94,150
Deferred Compensation Equity						$ 2,165,450			$ 2,165,450
G H S [Member]
Class of Stock [Line Items]
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value													$ 700,000
Preferred Stock, Shares Subscribed but Unissued													700
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number						941,599			941,599
G H S Tranche 1 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number						941,599			941,599
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants									$ 266,000
Proactive [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Subscribed but Unissued	160
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number						472,205			472,205
Proactive Two [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants									$ 155,000
G H S Tranche 2 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number				562,149		562,149			562,149
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants				$ 184,000
G H S Tranche 3 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number			281,074			281,074			281,074
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants			$ 92,000
G H S Tranche 4 [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number		281,074				281,074			281,074
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants		$ 92,000
Proactive Total [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants									$ 789,000
Warrant Allocated [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants									$ 721,275
Equity Incentive Plan [Member]
Class of Stock [Line Items]
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]			28,400,000
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]							793,039
[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]						8,400,000			8,400,000
[custom:VestingOfDeferredStockBasedCompensation]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights									4,200,000 shares of performance-based stock compensation are scheduled to vest on each of June 1, 2023 and June 1, 2024, respectively. The Company has elected to treat the award as a single award of 8,400,000 shares that vests ratably over the vesting period.
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized						1			1		1
Preferred Stock, Par or Stated Value Per Share						$ 0.001			$ 0.001		$ 0.001
Preferred Stock, Voting Rights									The holder of the Special 2019 Series A Preferred Stock is entitled to 60% of all votes entitled to vote at each meeting of stockholders of the Corporation (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Corporation for their action or consideration.
Preferred Stock, Shares Issued						1			1		1
Preferred Stock, Shares Outstanding						1			1		1
Series A Preferred Stock [Member] | Amendment To Series A Preferred [Member]
Class of Stock [Line Items]
Preferred Stock, Convertible, Terms					On March 12, 2021, the Company amended the designation of the Special 2019 Series A Preferred shares and removed the right of the holder to convert the Special 2019 Series A Preferred share to 500,000,000 shares of common stock of the Company.
Series A Preferred Stock [Member] | Preferred Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]
[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]
[custom:VestingOfDeferredStockBasedCompensation]
Preferred Class B [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized						0			0		0
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Par or Stated Value Per Share						$ 0.001			$ 0.001			$ 0.001
Preferred Stock, Shares Issued						0			0			0
Preferred Stock, Shares Outstanding						0			0			0
Preferred Stock, Conversion Basis								Holders of the Series B Preferred Stock shall after two years of issuance, convert this Class B Preferred Stock based on each Class B Preferred Share equaling .00001% of the total issued and outstanding Common shares of the Company. In the event of a merger, reorganization, recapitalization or similar event of or with respect to the Corporation (other than a Corporate Change in which the Corporation is the surviving entity), this Class B Preferred Stock shall be converted based on each Class B Preferred Share equaling .00001% of the total issued and outstanding shares of common stock of the Company
Series B Preferred Stock [Member] | Preferred Stock [Member]
Class of Stock [Line Items]
Conversion of Stock, Shares Converted											2
Conversion of Stock, Shares Issued											2,650
Conversion of Stock, Amount Converted											$ 6,000
Stock Issued During Period, Shares, New Issues
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]
[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]
[custom:VestingOfDeferredStockBasedCompensation]
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized						2,000			2,000		2,000		2,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001			$ 0.001		$ 0.001
Preferred Stock, Shares Issued						903			903		0
Preferred Stock, Shares Outstanding						903			903		0
Preferred Stock, Value, Outstanding													$ 1,200
Debt Instrument, Convertible, Terms of Conversion Feature									Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $1,200 of such share by the Conversion Price of $0.3202
Series C Preferred Stock [Member] | Preferred Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues						400	503
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]
[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]
[custom:VestingOfDeferredStockBasedCompensation]
Series C Preferred Stock [Member] | G H S Tranche 1 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues									300
Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage						75%			75%
Series C Preferred Stock [Member] | Commitment Shares [Member] | G H S Tranche 1 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues									35
Series C Preferred Stock [Member] | Commitment Shares [Member] | Proactive [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues									8
Series C Preferred Stock [Member] | Proactive [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues	168
Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage						75%			75%
Series C Preferred Stock [Member] | G H S Tranche 2 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				200
Series C Preferred Stock [Member] | G H S Tranche 3 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues			100
Series C Preferred Stock [Member] | G H S Tranche 4 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues		100

NOTE 12 - COMMITMENTS AND CON_2

NOTE 12 - COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended		12 Months Ended
	Mar. 25, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2022	Aug. 31, 2021
Other Commitments [Line Items]
Operating Lease, Payments		$ 4,264	$ 5,115
[custom:InvestorRelationsAgreementTerm]	6 months
Saunders [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description		The Company has entered into an employment agreement with Steven Saunders, our Chief Commercial Officer and Director. The term is three years commencing July 1, 2021. Mr. Saunders is to receive monthly cash compensation of $15,000 reduced by $3,820 until at least $5,000,000 funding has been received through the S-1 offering
Willard [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description				The Company has entered into an employment agreement with Rik Willard to act as Chief Executive Officer of the Company and as Director. The term is 1 year commencing August 15, 2021. Mr. Willard is to receive monthly cash compensation of $15,000 reduced by $3,000 until at least $5,000,000 funding has been received through the S-1 offering. Mr. Willard was also granted a signing bonus of 102,040 restricted shares, which were issued in June 2021
Willard Amended Agreement [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description				The employment agreement with Mr. Willard was amended as follows. In addition to his cash compensation the Company agreed to further compensate Mr. Willard in accordance with our May 25, 2022 Equity Incentive Plan (Note 11) with 5,400,000 restricted stock units, which vest 2,700,000 annually over a period of two years. He is also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He is also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Willard agreed to a two year non-solicit restrictive covenant. The agreement will automatically renew for a further year on May 31, 2023.
Saunders Amended Agreement [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description		The employment agreement with Mr. Saunders was amended as follows. In addition to his cash compensation the Company agreed to further compensate Mr. Saunders in accordance with our May 25, 2022 Equity Incentive Plan (Note 11) with 3,000,000 restricted stock units, which vests 1,500,000 annually over a period of two years. He is also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He is also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Saunders agreed to a two year non-solicit restrictive covenant
Morris [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description				The Company entered into employment agreement with Stephen Morris, our Founder and Chief Technology Officer, the term is three years commencing July 1, 2021. Mr. Morris is to receive monthly cash compensation of $15,000 reduced by $4,790 until at least $5,000,000 has been received through the S-1 offering.
P C G Advisory [Member]
Other Commitments [Line Items]
Payments to Suppliers		$ 7,000
Share-Based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost		7,000
New York Premisis [Member]
Other Commitments [Line Items]
Operating Lease, Payments		1,200	$ 0
Lessee, Operating Lease, Renewal Term					12 months
Operating Lease, Cost		$ 200

NOTE 13 - SUBSEQUENT EVENTS (De

NOTE 13 - SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Jul. 27, 2022	Jun. 30, 2022	Mar. 31, 2022	Mar. 31, 2021
Stock Issued During Period, Value, Issued for Services		$ 1,993,081	$ 8,980	$ 60,000
Investor Relations Services [Member]
Stock Issued During Period, Shares, Issued for Services	29,045
Stock Issued During Period, Value, Issued for Services	$ 7,000